Global Regorafenib Drugs Market Growth 2026-2032

June 2026 | 101 pages | ID: G02B792025AAEN
LP Information

Abstracts

The global Regorafenib Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Regorafenib tablets are a multi-kinase inhibitor ,which is used to treat various types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GISTs), and hepatocellular carcinoma (HCC).

United States market for Regorafenib Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Regorafenib Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Regorafenib Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Regorafenib Drugs players cover Bayer, Natco, Kelun Pharmaceutical, Hansoh Pharma, Chia Tai Tianqing Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Regorafenib Drugs Industry Forecast? looks at past sales and reviews total world Regorafenib Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Regorafenib Drugs sales for 2026 through 2032. With Regorafenib Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Regorafenib Drugs industry.

This Insight Report provides a comprehensive analysis of the global Regorafenib Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Regorafenib Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Regorafenib Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Regorafenib Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Regorafenib Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Regorafenib Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Original Drug
• Generic Drug

Segmentation by Application:

• Hepatocellular Carcinoma
• Metastatic Colorectal Cancer
• Gastrointestinal Stromal Tumors

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bayer
• Natco
• Kelun Pharmaceutical
• Hansoh Pharma
• Chia Tai Tianqing Pharmaceutical
• Zhejiang Huayi Pharmaceutical
• Qilu Pharmaceutical
• Shanghai Acebright Pharmaceuticals
• Yangtze River Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Regorafenib Drugs market?
What factors are driving Regorafenib Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Regorafenib Drugs market opportunities vary by end market size?
How does Regorafenib Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Regorafenib Drugs Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Regorafenib Drugs by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Regorafenib Drugs by Country/Region, 2021, 2025 & 2032
2.2 Regorafenib Drugs Segment by Type
  2.2.1 Original Drug
  2.2.2 Generic Drug
  2.2.3 Regorafenib Drugs Sales by Type
    2.2.3.1 Global Regorafenib Drugs Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Regorafenib Drugs Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Regorafenib Drugs Sale Price by Type (2021-2026)
2.3 Regorafenib Drugs Segment by Application
  2.3.1 Hepatocellular Carcinoma
  2.3.2 Metastatic Colorectal Cancer
  2.3.3 Gastrointestinal Stromal Tumors
  2.3.4 Regorafenib Drugs Sales by Application
    2.3.4.1 Global Regorafenib Drugs Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Regorafenib Drugs Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Regorafenib Drugs Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Regorafenib Drugs Breakdown Data by Company
  3.1.1 Global Regorafenib Drugs Annual Sales by Company (2021-2026)
  3.1.2 Global Regorafenib Drugs Sales Market Share by Company (2021-2026)
3.2 Global Regorafenib Drugs Annual Revenue by Company (2021-2026)
  3.2.1 Global Regorafenib Drugs Revenue by Company (2021-2026)
  3.2.2 Global Regorafenib Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Regorafenib Drugs Sale Price by Company
3.4 Key Manufacturers Regorafenib Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Regorafenib Drugs Product Location Distribution
  3.4.2 Players Regorafenib Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR REGORAFENIB DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Regorafenib Drugs Market Size by Geographic Region (2021-2026)
  4.1.1 Global Regorafenib Drugs Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Regorafenib Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Regorafenib Drugs Market Size by Country/Region (2021-2026)
  4.2.1 Global Regorafenib Drugs Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Regorafenib Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Regorafenib Drugs Sales Growth
4.4 APAC Regorafenib Drugs Sales Growth
4.5 Europe Regorafenib Drugs Sales Growth
4.6 Middle East & Africa Regorafenib Drugs Sales Growth

5 AMERICAS

5.1 Americas Regorafenib Drugs Sales by Country
  5.1.1 Americas Regorafenib Drugs Sales by Country (2021-2026)
  5.1.2 Americas Regorafenib Drugs Revenue by Country (2021-2026)
5.2 Americas Regorafenib Drugs Sales by Type (2021-2026)
5.3 Americas Regorafenib Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Regorafenib Drugs Sales by Region
  6.1.1 APAC Regorafenib Drugs Sales by Region (2021-2026)
  6.1.2 APAC Regorafenib Drugs Revenue by Region (2021-2026)
6.2 APAC Regorafenib Drugs Sales by Type (2021-2026)
6.3 APAC Regorafenib Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Regorafenib Drugs by Country
  7.1.1 Europe Regorafenib Drugs Sales by Country (2021-2026)
  7.1.2 Europe Regorafenib Drugs Revenue by Country (2021-2026)
7.2 Europe Regorafenib Drugs Sales by Type (2021-2026)
7.3 Europe Regorafenib Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Regorafenib Drugs by Country
  8.1.1 Middle East & Africa Regorafenib Drugs Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Regorafenib Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Regorafenib Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Regorafenib Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Regorafenib Drugs
10.3 Manufacturing Process Analysis of Regorafenib Drugs
10.4 Industry Chain Structure of Regorafenib Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Regorafenib Drugs Distributors
11.3 Regorafenib Drugs Customer

12 WORLD FORECAST REVIEW FOR REGORAFENIB DRUGS BY GEOGRAPHIC REGION

12.1 Global Regorafenib Drugs Market Size Forecast by Region
  12.1.1 Global Regorafenib Drugs Forecast by Region (2027-2032)
  12.1.2 Global Regorafenib Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Regorafenib Drugs Forecast by Type (2027-2032)
12.7 Global Regorafenib Drugs Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Bayer
  13.1.1 Bayer Company Information
  13.1.2 Bayer Regorafenib Drugs Product Portfolios and Specifications
  13.1.3 Bayer Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Bayer Main Business Overview
  13.1.5 Bayer Latest Developments
13.2 Natco
  13.2.1 Natco Company Information
  13.2.2 Natco Regorafenib Drugs Product Portfolios and Specifications
  13.2.3 Natco Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Natco Main Business Overview
  13.2.5 Natco Latest Developments
13.3 Kelun Pharmaceutical
  13.3.1 Kelun Pharmaceutical Company Information
  13.3.2 Kelun Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
  13.3.3 Kelun Pharmaceutical Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Kelun Pharmaceutical Main Business Overview
  13.3.5 Kelun Pharmaceutical Latest Developments
13.4 Hansoh Pharma
  13.4.1 Hansoh Pharma Company Information
  13.4.2 Hansoh Pharma Regorafenib Drugs Product Portfolios and Specifications
  13.4.3 Hansoh Pharma Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Hansoh Pharma Main Business Overview
  13.4.5 Hansoh Pharma Latest Developments
13.5 Chia Tai Tianqing Pharmaceutical
  13.5.1 Chia Tai Tianqing Pharmaceutical Company Information
  13.5.2 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
  13.5.3 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Chia Tai Tianqing Pharmaceutical Main Business Overview
  13.5.5 Chia Tai Tianqing Pharmaceutical Latest Developments
13.6 Zhejiang Huayi Pharmaceutical
  13.6.1 Zhejiang Huayi Pharmaceutical Company Information
  13.6.2 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
  13.6.3 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Zhejiang Huayi Pharmaceutical Main Business Overview
  13.6.5 Zhejiang Huayi Pharmaceutical Latest Developments
13.7 Qilu Pharmaceutical
  13.7.1 Qilu Pharmaceutical Company Information
  13.7.2 Qilu Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
  13.7.3 Qilu Pharmaceutical Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Qilu Pharmaceutical Main Business Overview
  13.7.5 Qilu Pharmaceutical Latest Developments
13.8 Shanghai Acebright Pharmaceuticals
  13.8.1 Shanghai Acebright Pharmaceuticals Company Information
  13.8.2 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product Portfolios and Specifications
  13.8.3 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Shanghai Acebright Pharmaceuticals Main Business Overview
  13.8.5 Shanghai Acebright Pharmaceuticals Latest Developments
13.9 Yangtze River Pharmaceutical
  13.9.1 Yangtze River Pharmaceutical Company Information
  13.9.2 Yangtze River Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
  13.9.3 Yangtze River Pharmaceutical Regorafenib Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Yangtze River Pharmaceutical Main Business Overview
  13.9.5 Yangtze River Pharmaceutical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Regorafenib Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Regorafenib Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Regorafenib Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Regorafenib Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Regorafenib Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Regorafenib Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Regorafenib Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Regorafenib Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Regorafenib Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Regorafenib Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Regorafenib Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Regorafenib Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Regorafenib Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Regorafenib Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Regorafenib Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Regorafenib Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Regorafenib Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Regorafenib Drugs Producing Area Distribution and Sales Area
Table 21. Players Regorafenib Drugs Products Offered
Table 22. Regorafenib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Regorafenib Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Regorafenib Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Regorafenib Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Regorafenib Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Regorafenib Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Regorafenib Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Regorafenib Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Regorafenib Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Regorafenib Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Regorafenib Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Regorafenib Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Regorafenib Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Regorafenib Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Regorafenib Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Regorafenib Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Regorafenib Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Regorafenib Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Regorafenib Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Regorafenib Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Regorafenib Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Regorafenib Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Regorafenib Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Regorafenib Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Regorafenib Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Regorafenib Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Regorafenib Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Regorafenib Drugs
Table 52. Key Market Challenges & Risks of Regorafenib Drugs
Table 53. Key Industry Trends of Regorafenib Drugs
Table 54. Regorafenib Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Regorafenib Drugs Distributors List
Table 57. Regorafenib Drugs Customer List
Table 58. Global Regorafenib Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Regorafenib Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Regorafenib Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Regorafenib Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Regorafenib Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Regorafenib Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Regorafenib Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Regorafenib Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Regorafenib Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Regorafenib Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Regorafenib Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Bayer Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Bayer Regorafenib Drugs Product Portfolios and Specifications
Table 74. Bayer Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Bayer Main Business
Table 76. Bayer Latest Developments
Table 77. Natco Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Natco Regorafenib Drugs Product Portfolios and Specifications
Table 79. Natco Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Natco Main Business
Table 81. Natco Latest Developments
Table 82. Kelun Pharmaceutical Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Kelun Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
Table 84. Kelun Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Kelun Pharmaceutical Main Business
Table 86. Kelun Pharmaceutical Latest Developments
Table 87. Hansoh Pharma Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Hansoh Pharma Regorafenib Drugs Product Portfolios and Specifications
Table 89. Hansoh Pharma Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Hansoh Pharma Main Business
Table 91. Hansoh Pharma Latest Developments
Table 92. Chia Tai Tianqing Pharmaceutical Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
Table 94. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Chia Tai Tianqing Pharmaceutical Main Business
Table 96. Chia Tai Tianqing Pharmaceutical Latest Developments
Table 97. Zhejiang Huayi Pharmaceutical Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
Table 99. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Zhejiang Huayi Pharmaceutical Main Business
Table 101. Zhejiang Huayi Pharmaceutical Latest Developments
Table 102. Qilu Pharmaceutical Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Qilu Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
Table 104. Qilu Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Qilu Pharmaceutical Main Business
Table 106. Qilu Pharmaceutical Latest Developments
Table 107. Shanghai Acebright Pharmaceuticals Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product Portfolios and Specifications
Table 109. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Shanghai Acebright Pharmaceuticals Main Business
Table 111. Shanghai Acebright Pharmaceuticals Latest Developments
Table 112. Yangtze River Pharmaceutical Basic Information, Regorafenib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Yangtze River Pharmaceutical Regorafenib Drugs Product Portfolios and Specifications
Table 114. Yangtze River Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Yangtze River Pharmaceutical Main Business
Table 116. Yangtze River Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Regorafenib Drugs
Figure 2. Regorafenib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Regorafenib Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Regorafenib Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Regorafenib Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Regorafenib Drugs Sales Market Share by Country/Region (2025)
Figure 10. Regorafenib Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Regorafenib Drugs Sales Market Share by Type in 2026
Figure 14. Global Regorafenib Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Regorafenib Drugs Consumed in Hepatocellular Carcinoma
Figure 16. Global Regorafenib Drugs Market: Hepatocellular Carcinoma (2021-2026) & (K Units)
Figure 17. Regorafenib Drugs Consumed in Metastatic Colorectal Cancer
Figure 18. Global Regorafenib Drugs Market: Metastatic Colorectal Cancer (2021-2026) & (K Units)
Figure 19. Regorafenib Drugs Consumed in Gastrointestinal Stromal Tumors
Figure 20. Global Regorafenib Drugs Market: Gastrointestinal Stromal Tumors (2021-2026) & (K Units)
Figure 21. Global Regorafenib Drugs Sale Market Share by Application (2025)
Figure 22. Global Regorafenib Drugs Revenue Market Share by Application in 2026
Figure 23. Regorafenib Drugs Sales by Company in 2026 (K Units)
Figure 24. Global Regorafenib Drugs Sales Market Share by Company in 2026
Figure 25. Regorafenib Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global Regorafenib Drugs Revenue Market Share by Company in 2026
Figure 27. Global Regorafenib Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Regorafenib Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Regorafenib Drugs Sales 2021-2026 (K Units)
Figure 30. Americas Regorafenib Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC Regorafenib Drugs Sales 2021-2026 (K Units)
Figure 32. APAC Regorafenib Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe Regorafenib Drugs Sales 2021-2026 (K Units)
Figure 34. Europe Regorafenib Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Regorafenib Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Regorafenib Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas Regorafenib Drugs Sales Market Share by Country in 2026
Figure 38. Americas Regorafenib Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas Regorafenib Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas Regorafenib Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Regorafenib Drugs Sales Market Share by Region in 2026
Figure 46. APAC Regorafenib Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC Regorafenib Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC Regorafenib Drugs Sales Market Share by Application (2021-2026)
Figure 49. China Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Regorafenib Drugs Sales Market Share by Country in 2026
Figure 57. Europe Regorafenib Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe Regorafenib Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe Regorafenib Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Regorafenib Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Regorafenib Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Regorafenib Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Regorafenib Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Regorafenib Drugs in 2026
Figure 74. Manufacturing Process Analysis of Regorafenib Drugs
Figure 75. Industry Chain Structure of Regorafenib Drugs
Figure 76. Channels of Distribution
Figure 77. Global Regorafenib Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global Regorafenib Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Regorafenib Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Regorafenib Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Regorafenib Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Regorafenib Drugs Revenue Market Share Forecast by Application (2027-2032)